Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma
Shiao‐Ya Hong, Yu-Rung Kao, Te‐Chang Lee, et al.
Cancer Research (2018) Vol. 78, Iss. 17, pp. 4984-4996
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Beyond K48 and K63: non-canonical protein ubiquitination
Michał Tracz, Wojciech Białek
Cellular & Molecular Biology Letters (2021) Vol. 26, Iss. 1
Open Access | Times Cited: 204
Non-proteolytic ubiquitylation in cellular signaling and human disease
Yongrong Liao, Izabela Sumara, Evanthia Pangou
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 40
KGF impedes TRIM21-enhanced stabilization of keratin 10 mediating differentiation in hypopharyngeal cancer
Fangyu Chai, Guangyi Wang, Yuqing Shen, et al.
Cellular Signalling (2025) Vol. 127, pp. 111614-111614
Closed Access | Times Cited: 1
Cell signaling and cancer: a mechanistic insight into drug resistance
Munmun Panda, Bijesh K. Biswal
Molecular Biology Reports (2019) Vol. 46, Iss. 5, pp. 5645-5659
Closed Access | Times Cited: 73
The ubiquitin system: orchestrating cellular signals in non-small-cell lung cancer
Qiang Fan, Qian Wang, Renjie Cai, et al.
Cellular & Molecular Biology Letters (2020) Vol. 25, Iss. 1
Open Access | Times Cited: 48
Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2
Shuaishuai Cui, Yuanyuan Chen, Yunfei Guo, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281536-e0281536
Open Access | Times Cited: 13
The Ubiquitin System: An Emerging Therapeutic Target for Lung Cancer
Jun‐O Jin, Nidhi Puranik, Quyen Thu Bui, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9629-9629
Open Access | Times Cited: 30
CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling
Limeng Pu, Manali Singha, J. Ramanujam, et al.
Oncotarget (2022) Vol. 13, Iss. 1, pp. 695-706
Open Access | Times Cited: 19
RNA-binding protein SOX2 promotes distal metastasis and cisplatin resistance in non-small cell lung cancer by stabilizing CBLC
Zhiyuan Zhuo, Bo Chen, H. Zhang, et al.
Molecular & Cellular Toxicology (2025)
Closed Access
Integrated multi-omics landscape of non-small cell lung cancer with distant metastasis
Teng He, Ting Jiang, Xiaoyuan Sun, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Emerging Roles and Research Tools of Atypical Ubiquitination
Qiuling Huang, Xiaofei Zhang
PROTEOMICS (2020) Vol. 20, Iss. 9
Closed Access | Times Cited: 30
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma
Martina Kirchner, Klaus Kluck, Regine Brandt, et al.
ESMO Open (2021) Vol. 6, Iss. 5, pp. 100253-100253
Open Access | Times Cited: 24
Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer
Jinhui Liu, Xing Chen, Yi Jiang, et al.
International Immunopharmacology (2020) Vol. 86, pp. 106735-106735
Closed Access | Times Cited: 25
UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
Hao Yang, Shan Gao, Jing Chen, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 24
Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma
Shiao‐Ya Hong, Yichun Lu, Shih-Hsin Hsiao, et al.
Oncogene (2022) Vol. 41, Iss. 13, pp. 1907-1917
Closed Access | Times Cited: 16
Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma
Guoyin Li, Zewen Song, Changjing Wu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 16
The functions and effects of CUL3-E3 ligases mediated non-degradative ubiquitination
Fengguang Zhai, Jingyun Li, Meng Ye, et al.
Gene (2022) Vol. 832, pp. 146562-146562
Closed Access | Times Cited: 16
PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway
Feng Lu, Jing Zhou, Qing Chen, et al.
Carcinogenesis (2022) Vol. 43, Iss. 7, pp. 624-634
Closed Access | Times Cited: 16
High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma
Rungui Niu, Yan-Lei Tang, Yanfeng Xi, et al.
Journal of Surgical Research (2020) Vol. 250, pp. 216-223
Closed Access | Times Cited: 23
A novel risk score system of immune genes associated with prognosis in endometrial cancer
Hongyu Zhou, Chufan Zhang, Haoran Li, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 20
RNF115-mediated ubiquitination of p53 regulates lung adenocarcinoma proliferation
Zhigang Luo, Xin Ye, Feng Shou, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 530, Iss. 2, pp. 425-431
Closed Access | Times Cited: 19
Comprehensive Analysis of E3 Ubiquitin Ligases Reveals Ring Finger Protein 223 as a Novel Oncogene Activated by KLF4 in Pancreatic Cancer
Lei Feng, Jieqing Wang, Jianmin Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 17
The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies
Jiaqi Ren, Linlin Lv, Xufeng Tao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Stochastic modelling of multistage carcinogenesis and progression of human lung cancer
Lingling Li, Tianhai Tian, Xinan Zhang
Journal of Theoretical Biology (2019) Vol. 479, pp. 81-89
Closed Access | Times Cited: 16
The role of an immune signature for prognosis and immunotherapy response in endometrial cancer.
Meng Yue, Yuebo Yang, Yu Zhang, et al.
American Journal of Translational Research (2021) Vol. 13, Iss. 2, pp. 532-548
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top